Market Closed -
Other stock markets
|
After market 19:30:37 | |||
309.4 USD | -1.73% | 314.6 | +1.68% |
05-22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
05-22 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.43% | 169B | |
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+2.81% | 162B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Mizuho Securities Cuts Amgen's Price Target to $194 From $222, Citing 'Potential 2022 Headwinds,' Says 'Valuations Could Be Even Lower;' Neutral Rating Kept